ArticleOncotarget2015

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery.

Chiara Romani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.